| First Author (yr) | Title | Citation | Data |
|---|
| Abram (2013) |
Effect of primary elvitegravir resistance mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. |
AAC |
|
| Adojaan (2005) |
Predominance of a rare type of HIV-1 in Estonia. |
JAIDS |
|
| Aghokeng (2007) |
Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages. |
Virology |
|
| Aghokeng (2009) |
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. |
Antivir Ther |
|
| Aghokeng (2011) |
High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity |
J Clin Microbiol |
|
| Aghokeng (2011) |
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. |
AIDS |
|
| Agwale (2006) |
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. |
ARHR |
|
| Ahuka-Mundeke (2010) |
Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon. |
J Gen Virol |
|
| Ait-Khaled (2002) |
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine, zidovudine in HIV-1 infected adults with no prior antiretroviral therapy. |
Antivir Ther |
|
| Ajoge (2012) |
Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in north-central Nigeria. |
ARHR |
|
| Akrim (2012) |
HIV-1 Subtype distribution in Morocco based on national sentinel surveillance data 2004-2005. |
AIDS Res Ther |
|
| Albert (1994) |
Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. |
J Virol |
|
| Albrecht (2000) |
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. |
ARHR |
|
| Albrecht (2001) |
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.AIDS Clinical Trials Group 364 Study Team. |
N Engl J Med |
|
| Alcantara (2013) |
Increasing heterosexual transmission of HIV-1 subtype C in inland central western Brazil |
J Med Virol |
|
| Alencar (2013) |
HIV genotypes and primary drug resistance among HIV seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV. |
JAIDS |
|
| Alizon (1986) |
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. |
Cell |
|
| An (2012) |
Reconstituting the epidemic history of HIV strain CRF01_AE among men who have sex with men (MSM) in Liaoning, northeastern China: implications for the expanding epidemic among MSM in China |
J Virol |
|
| Anderson (2000) |
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. |
J Virol |
|
| Andersson (1999) |
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in west Africa. |
Virology |
|
| Andresen (2007) |
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine. |
ARHR |
|
| Andries (2004) |
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. |
AAC |
|
| Apetrei (1998) |
Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. |
J Virol |
|
| Apetrei (2003) |
HIV type 1 diversity in northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy. |
ARHR |
|
| Apetrei (2005) |
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. |
J Virol |
|
| Arien (2005) |
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. |
AIDS |
|
| Ariyoshi (2003) |
Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. |
JAIDS |
|
| Arora (2008) |
Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India. |
ARHR |
|
| Arroyo (2004) |
HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. |
ARHR |
|
| Arroyo (2005) |
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. |
AIDS |
|
| Arruda (2010) |
Intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil. |
ARHR |
|
| Arruda (2010) |
Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in Sao Paulo City, Brazil. |
ARHR |
|
| Atkinson (2000) |
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine. |
J Infect Dis |
|
| Aulicino (2005) |
Sequence analysis of a south American HIV type 1 BC recombinant. |
ARHR |
|
| Aulicino (2005) |
Circulation of novel HIV type 1 A, B/C, and F subtypes in Argentina. |
ARHR |
|
| Aulicino (2011) |
Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12_BF pol gene mosaic patterns and high diversity of BF unique recombinant forms. |
Infect Genet Evol |
|
| Auwanit (2009) |
Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand. |
ARHR |
|
| Avi (2009) |
Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia. |
J Med Virol |
|
| Avi (2010) |
Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. |
ARHR |
|
| Avi (2011) |
Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. |
Scand J Infect Dis |
|
| Avila-Rios (2012) |
National prevalence and trends of HIV transmitted drug resistance in Mexico |
PLoS ONE |
|
| Ayouba (2009) |
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study. |
ARHR |
|
| Azijn (2010) |
TMC278, a next-generation NNRTI, active against wild-type and NNRTI-resistant HIV-1. |
AAC |
|
| Babic (2006) |
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004. |
Virus Res |
|
| Bacheler (2000) |
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. |
AAC |
|
| Bacheler (2001) |
Genotypic correlates of phenotypic resistance to Efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. |
J Virol |
|
| Badreddine (2007) |
Identification and characterization of hiv type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found. |
ARHR |
|
| Baier (1990) |
Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. |
Virology |
|
| Baker (2007) |
HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Balakrishnan (2005) |
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. |
ARHR |
|
| Balamane (2012) |
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine. |
AAC |
|
| Baldanti (2009) |
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens. |
J Med Virol |
|
| Baldrich-Rubio (2001) |
A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. |
J Gen Virol |
|
| Balode (2010) |
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia. |
J Med Virol |
|
| Balotta (2000) |
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. |
JAIDS |
|
| Balotta (2000) |
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region, outcome after treatment in recently infected individuals. |
Antivir Ther |
|
| Balotta (2001) |
Increasing prevalence of non-clade B HIV-1 strains heterosexuals, as monitored by the analysis of the RT and protease sequences. |
JAIDS |
|
| Bang (2008) |
Prevalence of primary antiretroviral resistance: trends in Korea. |
ARHR |
|
| Barber (2012) |
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. |
J Antimicrob Chemother |
|
| Barditch-Crovo (2001) |
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. |
AAC |
|
| Barlow (2003) |
Characterization of a novel simian immunodeficiency virus(SIVmonNG1) genome sequence from a mona monkey(cercopithecus mona). |
J Virol |
|
| Barnett (1993) |
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. |
J Virol |
|
| Barreto (2006) |
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. |
JAIDS |
|
| Bartolo (2009) |
HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. |
JAIDS |
|
| Bartolo (2009) |
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. |
AAC |
|
| Bartolo (2011) |
Origin and epidemiological history of HIV-1 CRF14_BG. |
PLoS One |
|
| Baxter (2000) |
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 study team for the Terry Beirn community programs for clinical research on AIDS. |
AIDS |
|
| Baxter (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Becker-Pergola (2000) |
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug naive Ugandan adults. |
ARHR |
|
| Beer (1999) |
Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C.lhoesti superspecies. |
J Virol |
|
| Beer (2000) |
Patterns of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir. |
J Virol |
|
| Beer (2001) |
Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria. |
J Virol |
|
| Belec (2000) |
High levels of drug resistance human immunodeficiency virus variants in patients exhibiting increasing CD4 + t cell counts despite virologic failure of protease inhibitors containing antiretroviral combination therapy. |
J Infect Dis |
|
| Bellocchi (2005) |
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme. |
J Med Virol |
|
| Bellosillo (2003) |
G190A substitution is associated with delavirdine(DLV) hypersusceptibility in vitro and clinical response with DLV intensification. |
Antivir Ther |
|
| Bernardin (2005) |
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. |
J Virol |
|
| Bessong (2005) |
Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. |
ARHR |
|
| Bessong (2006) |
Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals. |
ARHR |
|
| Bessong (2013) |
Genetic Analysis of HIV-1 Integrase Sequences from Treatment Naive Individuals in Northeastern South Africa. |
Int J Mol Sci |
|
| Bibollet-Ruche (2004) |
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). |
ARHR |
|
| Bibollet-Ruche (2004) |
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade. |
J Virol |
|
| Blanco (2011) |
HIV-1 integrase inhibitor resistance and its clinical implications. |
J Infect Dis |
|
| Bodelle (2004) |
Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. |
ARHR |
|
| Bonhoeffer (2004) |
Evidence for positive epistasis in HIV-1. |
Science |
|
| Bontell (2011) |
Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam. |
Infect Genet Evol |
|
| Bonura (2010) |
Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. |
ARHR |
|
| Bouchard (2007) |
HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Bouzeghoub (2006) |
High diversity of HIV type 1 in Algeria. |
ARHR |
|
| Bradshaw (2007) |
Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase. |
AAC |
|
| Brandin (2003) |
Pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. |
ARHR |
|
| Brehm (2011) |
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. |
JAIDS |
|
| Brehm (2012) |
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. |
Clin Infect Dis |
|
| Brennan (2000) |
Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma. |
ARHR |
|
| Brennan (2007) |
HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants. |
ARHR |
|
| Brennan (2008) |
The prevalence of diverse hiv-1 strains was stable in cameroonian blood donors from 1996 to 2004. |
JAIDS |
|
| Brennan (2009) |
Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. |
Transfusion |
|
| Brennan (2010) |
Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007. |
Transfusion |
|
| Brenner (2011) |
Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors |
J Med Virol |
|
| Brigido (2007) |
HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. |
ARHR |
|
| Brindeiro (2002) |
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. |
J Clin Microbiol |
|
| Brindeiro (1999) |
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. |
AAC |
|
| Brindeiro (2003) |
Brazilian network for HIV drug resistance surveillance (HIV-BResNet): a survey of chronically infected individuals. |
AIDS |
|
| Brockman (2012) |
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. |
J Virol |
|
| Brown (2009) |
Phylogenetic reconstruction of transmission events from individuals with acute HIV infection |
J Infect Dis |
|
| Brown (2000) |
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. |
J Virol |
|
| Brown (2005) |
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. |
J Virol |
|
| Brumme (2007) |
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. |
PLoS Pathog |
|
| Brumme (2009) |
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. |
PLoS Med |
|
| Brun (2001) |
Patterns of protease inhibitor cross resistance in viral isolates with reduced susceptibility to lopinavir. |
CROI 2001 |
|
| Bunupuradah (2011) |
Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens. |
Antivir Ther |
|
| Burda (2010) |
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon. |
J Med Virol |
|
| Burns (2002) |
Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes. |
ARHR |
|
| Bussmann (2005) |
HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. |
Antivir Chem Chemother |
|
| Bussmann (2011) |
Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. |
ARHR |
|
| Buzon (2008) |
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. |
Antivir Ther |
|
| Byrnes (1993) |
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. |
AAC |
|
| Cabana (1999) |
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. |
J Med Virol |
|
| Canducci (2009) |
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. |
AIDS |
|
| Canducci (2011) |
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir |
J Infect Dis |
|
| Cardoso (2009) |
HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from central west Brazil. |
J Clin Virol |
|
| Cardoso (2009) |
High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil. |
ARHR |
|
| Caride (2001) |
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. |
Virus Genes |
|
| Caron (2008) |
Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. |
ARHR |
|
| Caron (2012) |
Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. |
BMC Infect Dis |
|
| Carr (1996) |
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. |
J Virol |
|
| Carr (1998) |
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. |
Virology |
|
| Carr (1999) |
Direct Genbank submission: HIV-1 isolates from the Democratic Republic of the Congo and from Gabon. |
Direct Genbank Submission |
|
| Carr (1999) |
Characterization of subtype A HIV-1 from Africa by full genome sequencing. |
AIDS |
|
| Carr (2001) |
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. |
Virology |
|
| Carr (2001) |
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. |
AIDS |
|
| Carr (2005) |
HIV subtype and drug resistance patterns among drug-naive infected persons in Jos, Nigeria. |
Direct Genbank Submission |
|
| Carr (2005) |
Outbreak of west african recombinant of HIV-1 in Tashkent, Uzbekistan. |
JAIDS |
|
| Carr (2006) |
High genetic complexity of HIV-1 in low-prevalence, rural regions of Cameroon. |
Direct Genbank Submission |
|
| Carr (2010) |
HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?. |
Retrovirology |
|
| Carrillo (1998) |
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378. |
J Virol |
|
| Carrion (2003) |
Circulating recombinant form CRF02_AG in south America. |
ARHR |
|
| Carrion (2004) |
Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay. |
ARHR |
|
| Carvalho (2011) |
Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. |
ARHR |
|
| Casado (2003) |
Near full-length genome characterization of an HIV type 1 CRF05_DF virus from Spain. |
ARHR |
|
| Casado (2005) |
Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba. |
JAIDS |
|
| Castelbranco (2010) |
Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. |
ARHR |
|
| Castillo (2009) |
Surveillance of HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Castro (2010) |
HIV-1 drug resistance transmission networks in southwest Switzerland |
ARHR |
|
| Caumont (2001) |
Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh city, Vietnam. |
ARHR |
|
| Chaix (2003) |
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. |
AIDS |
|
| Chamberland (2012) |
Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. |
Sex Transm Infect |
|
| Chang (2008) |
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. |
J Antimicrob Chemother |
|
| Charpentier (2008) |
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. |
HIV Med |
|
| Charpentier (2011) |
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. |
Antivir Ther |
|
| Charpentier (2011) |
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. |
ARHR |
|
| Chaturbhuj (2010) |
Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. |
ARHR |
|
| Chen (2012) |
Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China |
BMC Infect Dis |
|
| Chen (2013) |
HIV-1 genotypes and drug resistance threshold survey in Honghe Prefecture of Yunnan Province in 2011 |
unpublished |
|
| Chen (1996) |
Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. |
J Virol |
|
| Chibo (2011) |
HIV transmissions during seroconversion contribute significantly to new infections in men who have sex with men in Australia. |
ARHR |
|
| Chin (2006) |
Inverse relationship between viral load and genotypic resistance mutations in Korean patients with primary HIV type 1 infections. |
ARHR |
|
| Chin (2010) |
Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. |
ARHR |
|
| Cho (2002) |
Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea. |
J Clin Microbiol |
|
| Chow (2012) |
Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia |
J Virol |
|
| Church (2007) |
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. |
ARHR |
|
| Church (2008) |
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. |
J Infect Dis |
|
| Ciccozzi (2005) |
Molecular diversity of HIV in Albania. |
J Infect Dis |
|
| Cinque (2001) |
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. |
ARHR |
|
| Clavel (1986) |
Isolation of a new human retrovirus from west African patients with AIDS. |
Science |
|
| Clevenbergh (2002) |
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1. |
Antivir Ther |
|
| Clewley (1998) |
A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus. |
J Virol |
|
| Coakley (2005) |
Atazanavir resistance in a protease inhibitor-naive patient treated with atazanavir/ritonavir associated with development of high-level atazanavir resistance and the N88S mutation in protease. |
CROI 2007 |
|
| Coakley (2000) |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. |
AIDS |
|
| Coetzer (2013) |
Extensive Drug Resistance in HIV-Infected Cambodian Children who are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines. |
ARHR |
|
| Colonno (2004) |
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. |
J Infect Dis |
|
| Condra (1995) |
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. |
Nature |
|
| Condra (1996) |
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. |
J Virol |
|
| Corbet (2000) |
Env sequences of SIV from chimpanzees in Cameroon are strongly related to HIV group N from the same geographic area. |
J Virol |
|
| Cornelissen (1997) |
Pol diversity of five HIV-1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. |
J Virol |
|
| Cornelissen (2000) |
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. |
J Gen Virol |
|
| Courgnaud (1992) |
Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. |
J Virol |
|
| Courgnaud (2001) |
Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family. |
J Virol |
|
| Courgnaud (2002) |
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. |
J Virol |
|
| Courgnaud (2003) |
Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus). |
J Virol |
|
| Courgnaud (2003) |
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. |
J Virol |
|
| Couto-Fernandez (2006) |
Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil. |
ARHR |
|
| Craig (1998) |
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. |
AIDS |
|
| Cuevas (2009) |
Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men. |
Euro Surveill |
|
| Cuevas (2002) |
High HIV-1 genetic diversity in Cuba. |
AIDS |
|
| Cuevas (2009) |
HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. |
JAIDS |
|
| da Silva (2010) |
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. |
J Antimicrob Chemother |
|
| da Silveira (2012) |
HIV type 1 molecular epidemiology in pol and gp41 genes among naive patients from Mato Grosso do Sul State, central western Brazil. |
ARHR |
|
| Dagnra (2011) |
High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lome, Togo. |
J Int AIDS Soc |
|
| Dalai (2009) |
Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. |
AIDS |
|
| Damond (2004) |
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. |
ARHR |
|
| Das (2004) |
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. |
J Med Chem |
|
| Das (2008) |
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. |
PNAS |
|
| Dau (2010) |
Connection domain mutations in treatment-experienced patients in the OPTIMA trial. |
JAIDS |
|
| Dauber (2002) |
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. |
J Virol |
|
| Dazza (2005) |
Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's mona monkey (Cercopithecus mona denti). |
J Virol |
|
| de Baar (2000) |
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. |
ARHR |
|
| De Gascun (2012) |
Human Immunodeficiency Virus Type 1 in Ireland: Phylogenetic Evidence for Risk Group-Specific Subepidemics. |
ARHR |
|
| de Medeiros (2011) |
Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naive population from Southernmost Brazil: Analysis of primary resistance mutations. |
J Med Virol |
|
| De Meyer (2009) |
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients. |
AIDS |
|
| de Sa Filho (2002) |
Mutations associated with drug resistance in a population of drug naive HIV-1 infected individuals. |
Direct Genbank Submission |
|
| de Sa Filho (2003) |
Analysis of the protease sequences of HIV-1 infected individuals after indinavir monotherapy. |
J Clin Virol |
|
| de Sa Filho (2005) |
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil. |
ARHR |
|
| de Sa Filho (2006) |
Identification of two HIV type 1 circulating recombinant forms in Brazil. |
ARHR |
|
| de Sa Filho (2008) |
HIV type 1 poltype 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil. |
ARHR |
|
| de Sa-Filho (2009) |
HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. |
ARHR |
|
| de Silva (2011) |
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form. |
ARHR |
|
| Dean (2011) |
Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study. |
ARHR |
|
| Deeks (1999) |
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. |
J Infect Dis |
|
| Deho (2008) |
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. |
ARHR |
|
| Delaugerre (2005) |
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF. |
J Clin Virol |
|
| Delaunay (2005) |
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021). |
J Virol |
|
| Delelis (2009) |
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo. |
AAC |
|
| Delgado (2001) |
Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study. |
ARHR |
|
| Delgado (2002) |
Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. |
JAIDS |
|
| Delgado (2008) |
High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study. |
JAIDS |
|
| Delgado (2010) |
Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile. |
ARHR |
|
| Delgado (2004) |
Genotypic (and phenotypic) predictors of a response to DDI monotherapy in ZDV-experienced patients. |
Antivir Ther |
|
| Delwart (2012) |
Genetic Diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. |
J Infect Dis |
|
| Demeter (2000) |
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). |
AAC |
|
| Dennis (2012) |
Phylogenetic insights into HIV transmission in North Carolina. |
AIDS |
|
| Derache (2007) |
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali. |
Antivir Ther |
|
| Derache (2008) |
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006. |
J Antimicrob Chemother |
|
| Descamps (1997) |
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. |
J Virol |
|
| Descamps (2010) |
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France |
J Antimicrob Chemother |
|
| Deshpande (2004) |
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. |
ARHR |
|
| Deshpande (2009) |
Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008. |
ARHR |
|
| Deshpande (2010) |
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines. |
ARHR |
|
| Deshpande (2011) |
Drug Resistance Mutations in HIV Type 1 isolates from naive patients eligible for first line antiretroviral therapy in JJ Hospital, Mumbai, India. |
ARHR |
|
| Dilernia (2007) |
HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. |
ARHR |
|
| Diop-Ndiaye (2010) |
Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal. |
ARHR |
|
| Djoko (2010) |
HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. |
ARHR |
|
| Djoko (2010) |
High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, DRC. |
ARHR |
|
| Doualla-Bell (2006) |
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. |
AAC |
|
| Doualla-Bell (2006) |
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. |
AAC |
|
| Dowling (2002) |
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. |
AIDS |
|
| Doyon (2005) |
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. |
Antiviral Res |
|
| Dueweke (1993) |
A mutation in reverse transcriptase of bis(heteroaryl)piperazine- resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. |
PNAS |
|
| Dumans (2002) |
Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. |
AAC |
|
| Dumans (2004) |
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. |
J Infect Dis |
|
| Dumans (2009) |
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure. |
Infect Genet Evol |
|
| Dunne (2001) |
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs. |
AIDS |
|
| Duque (2002) |
Prevalence of drug resistance and HIV-1 subtypes in antiretroviral inexperienced patients, during the year 2000 in Portugal. |
Direct Genbank Submission |
|
| Duque (2003) |
Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. |
Clin Microbiol Infect |
|
| El Annaz (2011) |
Presence of drug resistance mutations among drug-naive patients in Morocco. |
ARHR |
|
| El Annaz (2012) |
Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco. |
ARHR |
|
| El-Khatib (2010) |
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. |
AIDS |
|
| Ellenberger (1999) |
Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. |
ARHR |
|
| Escobar (2012) |
Transmitted drug-resistance in antiretroviral-naive HIV-infected population in El Salvador |
unpublished |
|
| Escoto-Delgadillo (2005) |
Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico. |
HIV Med |
|
| Eshleman (2001) |
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (HIV network for prevention trials 012 study). |
J Infect Dis |
|
| Eshleman (2001) |
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). |
J Infect Dis |
|
| Eshleman (2002) |
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. |
ARHR |
|
| Eshleman (2002) |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). |
JAIDS |
|
| Eshleman (2004) |
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. |
ARHR |
|
| Eshleman (2004) |
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine. |
JAIDS |
|
| Eshleman (2004) |
Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. |
J Clin Microbiol |
|
| Eshleman (2005) |
Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. |
ARHR |
|
| Eshleman (2005) |
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. |
J Infect Dis |
|
| Eshleman (2006) |
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations. |
ARHR |
|
| Eshleman (2007) |
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. |
AIDS |
|
| Eshleman (2009) |
Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. |
ARHR |
|
| Eshleman (2009) |
Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. |
AIDS |
|
| Espinosa (2004) |
Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. |
JAIDS |
|
| Etienne (2011) |
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms. |
Retrovirology |
|
| Eyer-Silva (2007) |
Autochthonous horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil. |
Mem Ins Oswaldo Cruz |
|
| Eygen (2012) |
Comparison of the Antivirogram and PhenoSense assays to determine phenotypic susceptibility to rilpivirine in patient samples from the Phase III ECHO and THRIVE trials |
unpublished |
|
| Eyzaguirre (2007) |
Genetic characterization of hiv-1 strains circulating in Kazakhstan. |
JAIDS |
|
| Falloon (2000) |
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity. |
Clin Infect Dis |
|
| Fang (2004) |
Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. |
J Infect Dis |
|
| Fernandez-Garcia (2010) |
Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. |
ARHR |
|
| Fernandez-Garcia (2012) |
The analysis of near full-length genome sequences of HIV-1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters. |
ARHR |
|
| Fernandez-Garcia (2009) |
Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia. |
ARHR |
|
| Ferradini (2011) |
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia. |
J Int AIDS Soc |
|
| Ferreira (2011) |
Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. |
J Med Virol |
|
| Ferreira (2010) |
Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically infected children in Belo Horizonte, Brazil. |
ARHR |
|
| Ferreira (2008) |
Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. |
Mem Ins Oswaldo Cruz |
|
| Ferreira (2013) |
Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil. |
Adv Virol |
|
| Fish (2010) |
Natural polymorphisms of integrase among HIV type 1-infected South African patients. |
ARHR |
|
| Fitzgibbon (1992) |
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. |
AAC |
|
| Fitzgibbon (2001) |
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens. |
ARHR |
|
| Florea (2011) |
HIV transmitted drug resistance in Romania 2007-2010 |
unpublished |
|
| Flores (1999) |
HIV-1 subtype F in single and dual infections in Puerto Rico: a potential sentinel site for monitoring novel genetic HIV variants in north America. |
Emerg Infect Dis |
|
| Fokam (2011) |
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon. |
Pediatr Infect Dis J |
|
| Foli (1996) |
In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-{2-(phosphonomethoxy)ethyl}adenine (PMEA). |
Antiviral Res |
|
| Fomsgaard (1991) |
A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. |
Virology |
|
| Fonjungo (2002) |
Human immunodeficiency virus type 1 group m protease in Cameroon: genetic diversity and protease inhibitor mutational features. |
J Clin Microbiol |
|
| Frange (2012) |
Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency. |
PLoS ONE |
|
| Fransen (2009) |
Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. |
J Virol |
|
| Fransen (2012) |
HIV-1 mutations at positions 143, 148, and 155 of integrase define different genetic barriers to raltegravir resistance in vivo. |
Journal of Virology |
|
| Frentz (2013) |
Limited cross-border infections in patients newly diagnosed with HIV in Europe. |
Retrovirology |
|
| Friend (2004) |
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen. |
AIDS |
|
| Fujisaki (2009) |
An 11-Year Surveillance of HIV type 1 subtypes in Nagoya, Japan. |
ARHR |
|
| Fujiwara (1998) |
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. |
AAC |
|
| Fukasawa (1988) |
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. |
Nature |
|
| Galkin (2006) |
Sequencing and analysis of full-length HIV-1 CRF06_cpx isolate from Russia. |
Direct Genbank Submission |
|
| Galkin (2006) |
Full-length genomic sequencing and analysis of four HIV type 1 subtype B isolates circulating in the territory of Russia. |
ARHR |
|
| Gallant (2005) |
Early virologic non-response to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral naive subjects. |
J Infect Dis |
|
| Galluzzo (2007) |
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda. |
ARHR |
|
| Gao (1992) |
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. |
Nature |
|
| Gao (1994) |
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. |
J Virol |
|
| Gao (1996) |
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. |
J Virol |
|
| Gao (1996) |
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization. |
J Virol |
|
| Gao (1998) |
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. |
J Virol |
|
| Gao (1998) |
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes. |
J Virol |
|
| Gao (1999) |
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. |
Nature |
|
| Gao (2001) |
Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. |
ARHR |
|
| Gao (2001) |
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. |
ARHR |
|
| Garcia-Bujalance (2005) |
Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. |
J Clin Microbiol |
|
| Garrido (2009) |
Dynamics in the selection of resistance mutations in HIV patients failing raltegravir and following its discontinuation. |
EUHIV DRW 2009 |
|
| Garrido (2009) |
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection. |
J Antimicrob Chemother |
|
| Garrido (2012) |
Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens. |
AAC |
|
| Gaspareto (2012) |
Genetic diversity and primary resistance among HIV-1-positive patients from Maringa, Parana, Brazil. |
Rev Inst Med Trop Sao Paulo |
|
| Gatanaga (1999) |
Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors. |
ARHR |
|
| Gatanaga (2007) |
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan |
Antiviral Res |
|
| Gatanaga (2010) |
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine. |
AAC |
|
| Germanaud (2010) |
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali |
AAC |
|
| Gibb (2002) |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). |
Antivir Ther |
|
| Gittens (2003) |
The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados. |
ARHR |
|
| Gody (2008) |
High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised who recommendations. |
JAIDS |
|
| Goethals (2008) |
Resistance mutations in HIV-1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors. |
J Virol |
|
| Goethals (2010) |
Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles. |
Virology |
|
| Gomez-Carrillo (2004) |
Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form. |
ARHR |
|
| Gong (2000) |
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. |
AAC |
|
| Gonsalez (2007) |
Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. |
Virus Res |
|
| Gonzales (2001) |
HIV-1 reverse transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a Northern California clinic-based population. |
J Infect Dis |
|
| Gonzales (2003) |
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. |
AIDS |
|
| Gonzales (2003) |
Protease and reverse transcriptase mutation patterns in HIV-1 isolates from heavily treated persons: comparison of isolates from northern California with isolates from other regions. |
ARHR |
|
| Gonzales (2003) |
Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing. |
JAIDS |
|
| Gonzalez (2003) |
Epidemiological and molecular characteristics of HIV and HTLV infection in Equatorial Guinea, 1996-1998. |
Direct Genbank Submission |
|
| Gonzalez (2010) |
Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia. |
ARHR |
|
| Gordon (2003) |
Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. |
J Virol |
|
| Graf (1998) |
Cloning and characterization of a virtually full-length HIV-1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in china. |
ARHR |
|
| Graf (2011) |
HIV-1 genetic diversity and drug resistance among treatment naive patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories. |
J Clin Virol |
|
| Green (2011) |
Drug resistance and coreceptor usage in HIV Type 1 Subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa. |
ARHR |
|
| Grossman (2004) |
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. |
AAC |
|
| Grossman (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Grossman (2005) |
Drug-resistant HIV infection among drug-naive patients in Israel. |
Clin Infect Dis |
|
| Guimaraes (2009) |
Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. |
Retrovirology |
|
| Gulick (2004) |
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Guo (2009) |
First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China. |
ARHR |
|
| Gupta (2011) |
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens |
AAC |
|
| Gurtler (1994) |
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. |
J Virol |
|
| Hachiya (2011) |
K70Q adds high-level tenofovir resistance to Q151M complex HIV reverse transcriptase through the enhanced discrimination mechanism. |
PLoS ONE |
|
| Haddad (2011) |
Mutation Y188L of HIV-1 reverse transcriptase is strongly associated with reduced susceptibility to rilpivirine |
CROI 2012 |
|
| Hai-Long (2007) |
Genetic characterization of CRF01_AE full-length human immunodeficiency virus type 1 sequences from Fujian, China. |
ARHR |
|
| Hall (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Hamers (2010) |
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia. |
JAIDS |
|
| Hamers (2011) |
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. |
Lancet |
|
| Hamkar (2010) |
Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. |
AIDS |
|
| Hammer (1997) |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. |
N Engl J Med |
|
| Han (2007) |
Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. |
ARHR |
|
| Han (2010) |
Genetic and epidemiologic characterization of HIV-1 infection In Liaoning Province, China. |
JAIDS |
|
| Handema (2002) |
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. |
ARHR |
|
| Hanna (2003) |
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. |
J Infect Dis |
|
| Harrigan (1996) |
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. |
J Virol |
|
| Harrigan (2002) |
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance. |
J Virol |
|
| Harrigan (2005) |
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. |
AIDS |
|
| Harris (2005) |
Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. |
ARHR |
|
| Harris (2003) |
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions. |
ARHR |
|
| Hasegawa (1989) |
Genomic divergence of HIV-2 from Ghana. |
ARHR |
|
| Hassan (2012) |
Low prevalence of transmitted HIV-1 drug resistance amongst ARV naive adults in a rural HIV clinic in Kenya. |
ARHR |
|
| Hatano (2010) |
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. |
JAIDS |
|
| Hawke (2013) |
HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia |
ARHR |
|
| Hawkins (2009) |
Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. |
JAIDS |
|
| Hazuda (2004) |
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. |
PNAS |
|
| Heredia (1997) |
Evidence of HIV-2 infection in Equatorial Guinea (Central Africa): partial genetic analysis of a B subtype virus. |
ARHR |
|
| Heredia (1997) |
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS. |
ARHR |
|
| Hertogs (2000) |
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. |
AAC |
|
| Hierholzer (2002) |
Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. |
ARHR |
|
| Hierholzer (2002) |
HIV type 1 strains from east and west Africa are intermixed in Sudan. |
ARHR |
|
| Hingankar (2012) |
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. |
Clin Infect Dis |
|
| Hirsch (1987) |
The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. |
Cell |
|
| Hirsch (1989) |
An African primate lentivirus (SIVsm) closely related to HIV-2. |
Nature |
|
| Hirsch (1993) |
A distinct African lentivirus from Sykes' monkeys. |
J Virol |
|
| Hirsch (1995) |
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. |
J Virol |
|
| Hirsch (1999) |
Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. |
J Virol |
|
| Ho (1994) |
Characterization of human immunodeficiency virus type1 variants with increased resistance to a C2-symmetric protease inhibitor. |
J Virol |
|
| Hoelscher (2001) |
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. |
AIDS |
|
| Hoffmann (2009) |
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa. |
Clin Infect Dis |
|
| Holguin (2000) |
Recombinant human immunodeficiency viruses type 1 circulating in Spain. |
ARHR |
|
| Holguin (2000) |
Protease gene analysis of HIV Type 1 non-B subtypes in Spain. |
ARHR |
|
| Holguin (2001) |
Prevalence of human immunodeficiency virus type 1 (HIV-1) Non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. |
J Clin Microbiol |
|
| Holguin (2002) |
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. |
AIDS |
|
| Holguin (2002) |
HIV-1 subtype J recombinant viruses in Spain. |
ARHR |
|
| Holguin (2003) |
HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe. |
HIV Clin Trials |
|
| Holguin (2004) |
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes. |
J Clin Virol |
|
| Holguin (2005) |
Heterogeneous nature of HIV-1 recombinants spreading in Spain. |
J Med Virol |
|
| Holguin (2005) |
Differences in the length of gag proteins among different HIV type 1 subtypes. |
ARHR |
|
| Holguin (2007) |
Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands. |
ARHR |
|
| Holguin (2008) |
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools. |
J Med Virol |
|
| Holguin (2008) |
Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. |
Curr HIV Res |
|
| Holzmayer (2005) |
Near-full-length genomic sequence of a human immunodeficiency type 1 subtype g strain from Cameroon. |
ARHR |
|
| Holzmayer (2009) |
Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain. |
ARHR |
|
| Hombrouck (2008) |
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. |
AAC |
|
| Hosseinipour (2009) |
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. |
AIDS |
|
| Howard (1996) |
Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. |
ARHR |
|
| Hsu (2005) |
Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore. |
JAIDS |
|
| Hu (2003) |
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. |
J Virol |
|
| Hu (2007) |
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. |
JAIDS |
|
| Huang (2003) |
Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. |
ARHR |
|
| Huang (2009) |
Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC). |
ARHR |
|
| Huang (2006) |
Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian province, China. |
Chin Med J (Engl) |
|
| Huang (1999) |
Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility. |
Antivir Ther |
|
| Huang (2000) |
A novel HIV-1 RT mutation (M230L) confers NNRTI resistance and dose-dependent stimulation of replication. |
Antivir Ther |
|
| Huang (2003) |
Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. |
J Virol |
|
| Huet (1990) |
Genetic organization of a chimpanzee lentivirus related to HIV-1. |
Nature |
|
| Hunt (2003) |
Characterization of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. |
Virus Genes |
|
| Iamarino (2012) |
BF integrase genes of HIV-1 circulating in Sao Paulo, Brazil, with a recurrent recombination region. |
PLoS ONE |
|
| Ibe (2008) |
Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity. |
ARHR |
|
| Ibe (2008) |
Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006. |
ARHR |
|
| Imamichi (2000) |
High-level resistance to 3'-azido-3'-deoxythymidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1. |
J Virol |
|
| Iqbal (2009) |
Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Isarangkura-Na-Ayuthaya (2010) |
Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01_AE integrase derived from drug-naive Thai Patients. |
ARHR |
|
| Ishikawa (1988) |
Isolation and characterization of HIV-2 from an AIDS patient in Ghana. |
AIDS |
|
| Ishizaki (2009) |
Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam. |
ARHR |
|
| Iweriebor (2012) |
Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa. |
Arch Virol |
|
| Jackson (2000) |
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. |
AIDS |
|
| Jacobs (2008) |
Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa. |
ARHR |
|
| Jacobsen (1995) |
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. |
Virology |
|
| Janssens (1999) |
HIV-1 subtype H near-full genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. |
AIDS |
|
| Janssens (2000) |
Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. |
ARHR |
|
| Jayaraman (2006) |
A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program. |
JAIDS |
|
| Jin (1994) |
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. |
EMBO J |
|
| Johnson (1990) |
Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. |
J Virol |
|
| Johnston (2003) |
High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. |
J Virol |
|
| Johnston (2004) |
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance. |
AAC |
|
| Johnston (2005) |
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations. |
AIDS |
|
| Jonassen (1997) |
Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. |
Virology |
|
| Jonassen (2000) |
Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. |
ARHR |
|
| Jones (2007) |
Resistance profile of HIV-1 mutants in vitro selected by the HIV-1 integrase inhibitor, GS-9137 (JTK-303). . |
CROI 2007 |
|
| Jones (2009) |
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. |
AAC |
|
| Jones (2009) |
In-depth analysis of the origins of HIV type 1 subtype C in south America. |
ARHR |
|
| Jones (2012) |
Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues. |
ARHR |
|
| Jorgensen (2000) |
Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine. |
Antivir Ther |
|
| Jorgensen (2003) |
Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. |
Scand J Infect Dis |
|
| Jullaksorn (2010) |
Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients. |
Southeast Asian J Trop Med Public Health |
|
| K'Aluoch (2005) |
Characterization of HIV-1 subtypes and recombinants in a Uganda cohort by use of the gag, nef and pol genes. |
Direct Genbank Submission |
|
| Kagan (2005) |
Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir. |
Protein Sci |
|
| Kagan (2007) |
Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. |
Antiviral Res |
|
| Kagan (2009) |
Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples. |
AIDS |
|
| Kamoto (2008) |
Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. |
Antivir Ther |
|
| Kandathil (2009) |
A comparison of interpretation by three different HIV type 1 genotypic drug resistance algorithms using sequences from non-clade B HIV type 1 strains. |
ARHR |
|
| Kandathil (2009) |
The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India. |
Int J STD AIDS |
|
| Kane (2001) |
Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal. |
ARHR |
|
| Kantor (2002) |
Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy. |
AAC |
|
| Kantor (2002) |
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. |
ARHR |
|
| Kao (2011) |
Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan. |
ARHR |
|
| Karlsson (2012) |
Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. |
PLoS ONE |
|
| Kasang (2011) |
HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. |
PLoS ONE |
|
| Kassaye (2009) |
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. |
JAIDS |
|
| Kassu (2007) |
Molecular epidemiology of HIV-1 in treatment-naive patients in north Ethiopia. |
ARHR |
|
| Katzenstein (2000) |
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. |
ARHR |
|
| Katzenstein (2001) |
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. |
ARHR |
|
| Kaye (2002) |
Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial). |
Antivir Ther |
|
| Keele (2006) |
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. |
Science |
|
| Keele (2009) |
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. |
Nature |
|
| Kellam (1992) |
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. |
PNAS |
|
| Kellam (1994) |
Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance. |
J Gen Virol |
|
| Kempf (2001) |
Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. |
J Virol |
|
| Kijak (2001) |
Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina. |
Antivir Ther |
|
| Kijak (2004) |
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. |
ARHR |
|
| Kijak (2012) |
HIV-1 Prevalence and Subtype Distribution in HIV-1 Positive Volunteers Deferred from Enrollment in a Phase III Prime-Boost HIV-1 Vaccine Trial in Thailand |
unpublished |
|
| Kim (2011) |
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naıve patients with HIV/AIDS in Korea |
Clin Microbiol Infect |
|
| King (2006) |
Phenotypic susceptibility to TMC-114 and tipranavir before and after lopinavir/ritonavir-based treatment in subjects demonstrating evolution of lopinavir resistance. |
IHDRW 2006 |
|
| Kinomoto (2005) |
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. |
Clin Infect Dis |
|
| Knops (2010) |
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V. |
AIDS |
|
| Knops (2010) |
Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates. |
J Antimicrob Chemother |
|
| Kobayashi (2011) |
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor |
AAC |
|
| Koch (2001) |
Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant. |
ARHR |
|
| Koizumi (2006) |
Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. |
JAIDS |
|
| Konings (2004) |
Protease mutations in HIV-1 non-B strains infecting drug-naive villagers of Cameroon. |
ARHR |
|
| Konings (2004) |
V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon. |
ARHR |
|
| Koulinska (2001) |
A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. |
ARHR |
|
| Koulinska (2002) |
Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. |
ARHR |
|
| Kousiappa (2009) |
Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: high genetic diversity and low prevalence of drug resistance. |
ARHR |
|
| Kousiappa (2009) |
Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection. |
ARHR |
|
| Kousiappa (2011) |
Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance. |
ARHR |
|
| Koyalta (2009) |
High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad. |
Clin Infect Dis |
|
| Kulkarni (2012) |
The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness. |
JAIDS |
|
| Kumar (1990) |
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. |
J Virol |
|
| Kuritzkes (2004) |
Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens. |
JAIDS |
|
| Kurle (2007) |
Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in hiv type 1 subtype C infected infants in India. |
ARHR |
|
| Kusagawa (2003) |
Identification of HIV type 2 subtype B transmission in East Asia. |
ARHR |
|
| Lacey (1994) |
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'- dideoxythymidine in cell culture. |
AAC |
|
| Laeyendecker (2005) |
Molecular epidemiology of HIV-1 subtypes in southern China. |
JAIDS |
|
| Lahuerta (2008) |
Rapid spread and genetic diversification of hiv type 1 subtype C in a rural area of southern Mozambique. |
ARHR |
|
| Lakhashe (2008) |
Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. |
ARHR |
|
| Lall (2008) |
Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India. |
ARHR |
|
| Lam (2003) |
Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation. |
Clin Infect Dis |
|
| Lama (2006) |
Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. |
JAIDS |
|
| Lan (2003) |
HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh city(Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. |
ARHR |
|
| Land (2008) |
Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants. |
ARHR |
|
| Lanier (2004) |
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens. |
HIV Med |
|
| Larder (1992) |
3'-Azido-3'-Deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Larder (1993) |
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. |
Nature |
|
| Larder (1999) |
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. |
AAC |
|
| Lataillade (2007) |
Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. |
Antivir Ther |
|
| Laukkanen (1999) |
Virtually full-length sequences of HIV type 1 subtype J reference strains. |
ARHR |
|
| Laukkanen (2000) |
Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. |
Virology |
|
| Laurent (2006) |
Antiretroviral drug resistance and routine therapy, Cameroon. |
Emerg Infect Dis |
|
| Lawrence (1999) |
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons. |
J Infect Dis |
|
| Lawrence (2006) |
Analysis of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02-AG subtypes from drug-naive patients from Saint-Etienne, France. |
JAIDS |
|
| Lazaro (2011) |
Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159). |
PLoS ONE |
|
| Lee EJ (2005) |
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. |
J Infect Dis |
|
| Lee (2009) |
Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore. |
HIV Med |
|
| Lee (2012) |
Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 |
PLoS ONE |
|
| Lennerstrand (2001) |
Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine. |
AAC |
|
| Li (2007) |
Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. |
J Virol |
|
| Li (2012) |
Screening for and Verification of Novel Mutations Associated with Drug Resistance in the HIV Type 1 subtype B(') in China |
PLoS ONE |
|
| Li (2010) |
Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China. |
ARHR |
|
| Li (2010) |
Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China. |
ARHR |
|
| Li (2013) |
Genetic Characterization and Transmitted Drug Resistance of the HIV Type 1 Epidemic in Men Who Have Sex with Men in Beijing, China |
ARHR |
|
| Li (2010) |
Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B. |
JAIDS |
|
| Li (2011) |
High prevalence of HIV type 1 subtype B' among heterosexuals in Western Hubei, Central China: Bridging the epidemic into the general population. |
ARHR |
|
| Li (2012) |
The in vitro cross-resistance profile of the NRTI BMS-986001 against known NRTI resistance mutations |
IWHHVDR 2012 |
|
| Liao (2009) |
Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. |
Virology |
|
| Liao (2007) |
genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China. |
ARHR |
|
| Liegeois F (2009) |
Full-length genome characterization of a novel simian immunodeficiency virus lineage (SIVolc) from olive Colobus (Procolobus verus) and new SIVwrcPbb strains from Western Red Colobus (Piliocolobus badius badius) from the Tai Forest in Ivory Coast. |
J Virol |
|
| Liegeois (2006) |
Molecular characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis). |
Virology |
|
| Liegeois (2011) |
Full-Length Genome Sequence of a Simian Immunodeficiency Virus from a Wild-Captured Sun-Tailed Monkey in Gabon Provides Evidence for a Species-Specific Monophyletic SIVsun Lineage. |
ARHR |
|
| Liitsola (2000) |
An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. |
ARHR |
|
| Lin (1994) |
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. |
J Infect Dis |
|
| Lin (2007) |
Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan. |
J Infect Dis |
|
| Lindstrom (2006) |
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men. |
Antivir Ther |
|
| Little (2002) |
Antiretroviral-drug resistance among patients recently infected with HIV. |
N Engl J Med |
|
| Liu (2007) |
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian province, China. |
Arch Virol |
|
| Liu (2005) |
Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China. |
JAIDS |
|
| Liu (2007) |
Polymorphism and antiretroviral drug resistance patterns in the protease gene of HIV-1 subtypes infecting PI naive Chinese patients. |
Direct Genbank Submission |
|
| Lloyd (2008) |
Prevalence of resistance mutations in HIV-1 infected Hondurans at the beginning of the national antiretroviral therapy program. |
ARHR |
|
| Locatelli (2008) |
Full molecular characterization of a simian immunodeficiency virus, SIVwrcpbt from Temminck's red colobus (Piliocolobus badius temminckii) from Abuko Nature Reserve, The Gambia. |
Virology |
|
| Lole (1999) |
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. |
J Virol |
|
| Low (2009) |
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. |
AAC |
|
| Luebbert (2012) |
Virological Failure and Drug Resistance in Patients on Antiretroviral Therapy After Treatment Interruption in Lilongwe, Malawi. |
Clin Infect Dis |
|
| Luk (2001) |
Naturally occurring sequence polymorphisms within HIV type 1 group O protease. |
ARHR |
|
| Luk (2007) |
Near full-length genome characterization of three additional HIV type 1 CRF13_cpx strains from Cameroon. |
ARHR |
|
| Luk (2008) |
Near full-length genome characterization of an HIV type 1 CRF25_cpx strain from Cameroon. |
ARHR |
|
| Luo (2009) |
Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China. |
JAIDS |
|
| Luu (2012) |
HIV type 1 coreceptor tropism, CCR5 genotype, and integrase inhibitor resistance profiles in Vietnam: implications for the introduction of new antiretroviral regimens. |
ARHR |
|
| Lwembe (2007) |
Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure. |
J Med Virol |
|
| Ly (2005) |
Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs. |
ARHR |
|
| Ly (2007) |
Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission. |
ARHR |
|
| Machado (2002) |
Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. |
AIDS |
|
| Machado (2004) |
Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil. |
An Acad Bras Cienc |
|
| Machado (2004) |
Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. |
J Clin Virol |
|
| Machado (2004) |
Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. |
Pediatr Infect Dis J |
|
| Machado (2009) |
Molecular epidemiology of HIV type 1 in northern Brazil: identification of subtypes C and D and the introduction of CRF02_AG in the Amazon region of Brazil. |
ARHR |
|
| Machado (2012) |
HIV type 1 genetic diversity in newly diagnosed Cuban patients. |
ARHR |
|
| Machado (2012) |
Transmitted HIV Type 1 Drug Resistance in Newly Diagnosed Cuban Patients. |
ARHR |
|
| Madsen (2007) |
Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from Greenland. |
ARHR |
|
| Maguire (2002) |
Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. |
AAC |
|
| Maia Teixeira (2006) |
Trends in drug resistance mutations in antiretroviral-naive intravenous drug users of Rio de Janeiro. |
J Med Virol |
|
| Maiga (2010) |
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes. |
AAC |
|
| Malet (2008) |
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. |
AAC |
|
| Malet (2011) |
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype. |
J Antimicrob Chemother |
|
| Maljkovic (2003) |
Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE. |
ARHR |
|
| Mamadou (2003) |
Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. |
ARHR |
|
| Manasa (2011) |
Primary drug resistance in South Africa - data from 20 years of surveys. |
ARHR |
|
| Manosuthi (2010) |
Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. |
ARHR |
|
| Marconi (2008) |
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. |
Clin Infect Dis |
|
| Marechal (2006) |
Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: a 2005 study. |
ARHR |
|
| Margot (2002) |
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. |
AIDS |
|
| Margot (2006) |
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 |
HIV Med |
|
| Margot (2012) |
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4 |
Antiviral Res |
|
| Markowitz (1998) |
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection. |
J Infect Dis |
|
| Martinson (2007) |
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. |
JAIDS |
|
| Marx (1991) |
Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. |
J Virol |
|
| Masciotra (2000) |
Evidence of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina. |
ARHR |
|
| Masharsky (2003) |
Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union. |
ARHR |
|
| Masquelier (1999) |
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study. |
Antivir Ther |
|
| Masquelier (2001) |
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. |
AAC |
|
| Masquelier (2002) |
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR study. |
J Infect Dis |
|
| Matthews (2008) |
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. |
J Virol |
|
| Maxeiner (2002) |
Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients. |
J Infect Dis |
|
| McClutchan (2002) |
Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. |
ARHR |
|
| McColl (2010) |
Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy. |
Antiviral Res |
|
| McConnell (2008) |
Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain. |
ARHR |
|
| McCutchan (2004) |
HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. |
ARHR |
|
| McGrath (2007) |
Antiviral efficacy and emergent PI substitutions in treatment-naive subjects receiving atazanavir +/- ritonavir-based HAART in subtype b and non-type b HIV-1 infection. |
IHDRW 2007 |
|
| McIntosh (1991) |
Complete genome sequence of a Cambridge isolate of human immunodeficiency virus type 1. |
Direct Genbank Submission |
|
| McLaughlin (2004) |
Sequence diversity of HIV-1 genomes from the HIV vaccine trials network. |
Direct Genbank Submission |
|
| McNulty (2007) |
Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. |
J Clin Microbiol |
|
| Megede (2002) |
Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa. |
ARHR |
|
| Melikian (2012) |
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility. |
AAC |
|
| Mellors (1995) |
Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. |
AAC |
|
| Meloni (2004) |
Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. |
J Virol |
|
| Mesplede (2013) |
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure. |
Retrovirology |
|
| Mezei (2011) |
Molecular Epidemiological Analysis of env and pol Sequences in Newly Diagnosed HIV Type 1-Infected, Untreated Patients in Hungary. |
ARHR |
|
| Milazzo (1999) |
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. |
JAIDS |
|
| Miller (2003) |
Characterization of resistance mutation patterns emerging over 2 years during first-line antiretroviral treatment with tenofovir DF or stavudine and efavirenz. |
Antivir Ther |
|
| Miller (2000) |
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. |
AIDS |
|
| Mintsa-Ndong (2009) |
High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa. |
ARHR |
|
| Mitsuya (2006) |
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure. |
ARHR |
|
| Miura (2008) |
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes |
J Virol |
|
| Mo (2005) |
Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates. |
J Virol |
|
| Mo (2006) |
Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to HIV protease inhibitors and impair viral replication. |
AAC |
|
| Mokili (2002) |
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo. |
ARHR |
|
| Molla (1996) |
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. |
Nat Med |
|
| Monleau (2012) |
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations. |
ARHR |
|
| Monno (2003) |
HIV-1 phenotypic susceptibility to lopinavir(LPV) and genotypic analysis in LPV/r-Naive subjects with prior protease inhibitor experience. |
JAIDS |
|
| Monno (2003) |
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART. |
J Med Virol |
|
| Montavon (1999) |
The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. |
ARHR |
|
| Montavon (2000) |
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. |
JAIDS |
|
| Montavon (2002) |
CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. |
JAIDS |
|
| Montavon (2002) |
Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. |
ARHR |
|
| Montes (2004) |
Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. |
JAIDS |
|
| Mosha (2010) |
Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania. |
ARHR |
|
| Moussa (2010) |
First data on HIV-1 resistance mutations to antiretroviral drugs in Central African Republic. |
ARHR |
|
| Mueller (2004) |
Susceptibility to saquinavir and atazanavir in highly protease inhibitor(PI) resistant HIV-1 is caused by lopinavir-induced drug resistance mutation L76V. |
Antivir Ther |
|
| Mulato (1998) |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy. |
AAC |
|
| Murillo (2012) |
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America. |
J Med Virol |
|
| Murphy (2004) |
HIV protease mutations associated with amprenavir resistance during salvage therapy: importance of I54M. |
J Clin Virol |
|
| Murphy (1999) |
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. |
J Infect Dis |
|
| Musyoki (2012) |
Genetic Characterization of HIV Before Widespread Testing of HIV Vaccine Candidates at a Clinical Trial Site in Pretoria, South Africa. |
ARHR |
|
| Mwaengo (1998) |
Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic HIV-1 infections. |
J Virol |
|
| Nadai (2009) |
HIV-1 epidemic in the Caribbean is dominated by subtype B. |
PLoS ONE |
|
| Nakahara (2009) |
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics. |
Antiviral Res |
|
| Nasioulas (1999) |
Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. |
ARHR |
|
| Naugler (2002) |
T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. |
J Infect Dis |
|
| Nazziwa (2012) |
HIV-1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral naive individuals from Ugandan fishing communities of Lake Victoria |
ARHR |
|
| Ndembi (2008) |
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. |
J Clin Microbiol |
|
| Ndembi (2008) |
Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. |
ARHR |
|
| Ndembi (2010) |
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus nevirapine and zidovudine-lamivudine plus abacavir. |
J Infect Dis |
|
| Ndembi (2011) |
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. |
AIDS |
|
| Ndongmo (2006) |
HIV genetic diversity in Cameroon: possible public health importance. |
ARHR |
|
| Neilson (1999) |
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. |
J Virol |
|
| Neogi (2010) |
Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naive individuals in Bangalore, India. |
ARHR |
|
| Nerrienet (2005) |
Simian immunodeficiency virus infection in wild-caught chimpanzees from Cameroon. |
J Virol |
|
| Ng (2012) |
Genome sequence of a novel HIV-1 circulating recombinant form 54_01B from Malaysia |
J Virol |
|
| Ng (2011) |
Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms. |
ARHR |
|
| Ng (2011) |
Identification of New CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. |
ARHR |
|
| Ngo-Giang-Huong (2011) |
Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis |
PLoS ONE |
|
| Nguyen (2008) |
HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. |
Antivir Ther |
|
| Niama (2009) |
CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL. |
ARHR |
|
| Nijhuis (1997) |
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo. |
J Infect Dis |
|
| Nijhuis (2009) |
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V. |
J Infect Dis |
|
| Njai (2006) |
The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. |
Retrovirology |
|
| Njouom (2003) |
Assessment of HIV-1 subtyping for Cameroom strains using phylogenetic analysis of pol gene sequences. |
J Virol Methods |
|
| Nkengasong (2000) |
Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire. |
JAIDS |
|
| Non-B Workgroup (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Nouhin (2009) |
Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia. |
ARHR |
|
| Nouhin (2011) |
Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study. |
Infect Genet Evol. |
|
| Novembre (1992) |
SIV from stump-tailed macaques: molecular characterization of a highly transmissable primate lentivirus. |
Virology |
|
| Novitsky (2002) |
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? |
J Virol |
|
| Novitsky (2007) |
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in Southern Africa. |
ARHR |
|
| Novitsky (1999) |
Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. |
J Virol |
|
| Novitsky (1999) |
HIV-1 A/J recombinant with a pronounced pol gene mosaicism. |
ARHR |
|
| Ntemgwa (2008) |
Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada. |
ARHR |
|
| Nukoolkarn (2004) |
Sequence variability of the HIV type 1 protease gene in Thai patients experienced with antiretroviral therapy. |
ARHR |
|
| Nwobegahay (2011) |
Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. |
S Afr Med J |
|
| Nwobegahay (2011) |
Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa. |
J Health Popul Nutr |
|
| Nwobegahay (2012) |
Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa. |
J Med Virol |
|
| Nyombi (2008) |
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. |
ARHR |
|
| Ochoa de Echaguen (2005) |
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir. |
AIDS |
|
| Oelrichs (1998) |
A novel subtype A/G/J recombinant full-length HIV Type 1 genome from Burkina Faso. |
ARHR |
|
| Oelrichs (1999) |
Full-length genomic sequence of a subtype G HIV-1 from Kinshasa. |
ARHR |
|
| Oette (2006) |
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. |
JAIDS |
|
| Ojesina (2006) |
Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. |
ARHR |
|
| Ojesina (2007) |
Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria. |
ARHR |
|
| Oliveira (2012) |
Genetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: implications for integrase inhibitors. |
ARHR |
|
| Onanga (2006) |
SIVsun natural history in Cercopithecus solatus and Macaca fascicularis: evidence of a common ''Evolution Profile'' in African monkeys related to the lack of pathogeny of SIVs in natural host. |
Direct Genbank Submission |
|
| Op de Coul (2000) |
Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors and to children. |
ARHR |
|
| Op de Coul (2000) |
Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands. |
Virology |
|
| Orlandi (1998) |
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine. |
JAIDS |
|
| Orrell (2009) |
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. |
Antivir Ther |
|
| Palacios (2008) |
Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Malaga (Spain). |
Enferm Infecc Microbiol Clin |
|
| Palma (2007) |
Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. |
Infect Genet Evol |
|
| Palmer (1999) |
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. |
AIDS |
|
| Pando (2006) |
First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. |
Retrovirology |
|
| Pandrea (2001) |
Hiv type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova. |
ARHR |
|
| Pandrea (2002) |
Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon. |
ARHR |
|
| Papa (2002) |
Genetic variation of the protease and reverse transcriptase genes in HIV-1 CRF04_cpx strains. |
ARHR |
|
| Papa (2002) |
HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece. |
Virus Res |
|
| Papathanasopoulos (2002) |
Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. |
ARHR |
|
| Papathanasopoulos (2003) |
Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. |
ARHR |
|
| Papathanasopoulos (2010) |
Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS vaccine integrated project (AVIP) study. |
ARHR |
|
| Paraschiv (2007) |
Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains. |
Int J Infect Dis |
|
| Paraskevis (2000) |
Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. |
ARHR |
|
| Paraskevis (2001) |
Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. |
J Gen Virol |
|
| Paraskevis (2005) |
Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. |
Virus Res |
|
| Parboosing (2011) |
Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa. |
J Med Virol |
|
| Parczewski (2012) |
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland. |
BMC Infect Dis |
|
| Pariente (2004) |
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes. |
J Med Virol |
|
| Park (2003) |
Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy. |
ARHR |
|
| Parker (2007) |
Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naive, HIV-infected individuals in New York State. |
AIDS Patient Care STDS |
|
| Parkin (2000) |
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients. |
AIDS |
|
| Parkin (2001) |
Discordance between genotype-based predictions of protease inhibitor susceptibility and actual phenotype in HIV-1 isolates containing mutations at positions 82 and 90: Modulatory effects of mutations at secondary positions. |
ICAAC 2000 |
|
| Parkin (2001) |
Genotypic and phenotypic analysis of a large database of patient samples reveals distinct patterns of protease inhibitor cross-resistance. |
Antivir Ther |
|
| Parkin (2003) |
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. |
AAC |
|
| Parkin (2003) |
HIV-1 reverse transcriptase mutations that suppress zidovudine resistance also increase in vitro susceptibility to tenofovir, but not stavudine. |
IHDRW 2003 |
|
| Parkin (2006) |
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Parreira (2004) |
Natural polymorphism of HIV-1 subtype G protease and cleavage sites. |
AIDS |
|
| Parreira (2006) |
Genetic characterization of human immunodeficiency virus type 1 from Beira, Mozambique |
Microbes Infect |
|
| Partaledis (1995) |
In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease. |
J Virol |
|
| Pasquier (2001) |
HIV-1 subtyping using phylogenetic analysis of pol gene sequences. |
J Virol Methods |
|
| Passaes (2009) |
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. |
JAIDS |
|
| Passaes (2009) |
Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil. |
ARHR |
|
| Patick (1996) |
Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. |
AAC |
|
| Patick (1998) |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. |
AAC |
|
| Peeters (1999) |
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. |
J Virol |
|
| Pellegrin (1999) |
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. |
AIDS |
|
| Perez (2001) |
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. |
J Infect Dis |
|
| Perez (2006) |
HIV Type 1 molecular epidemiology in Cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms. |
ARHR |
|
| Perez-Alvarez (2001) |
HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease. |
AIDS |
|
| Perno (2001) |
Impact of mutations conferring reduced susceptibility to lamivudine(3TC) on the response to antiretroviral therapy. |
Antivir Ther |
|
| Petch (2005) |
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. |
ARHR |
|
| Petroni (2006) |
Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. |
JAIDS |
|
| Petropoulos (2000) |
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. |
AAC |
|
| Phan (2010) |
Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam. |
ARHR |
|
| Pieniazek (1998) |
Evidence for the introduction of multiple HIV-1 subtypes in Lebanon. |
Emerg Infect Dis |
|
| Pieniazek (2004) |
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1. |
AIDS |
|
| Pieniazek (2004) |
HIV-1 complex recombinant was the predominant strain in Burkina Faso by the mid-1980s. |
CROI 2004 |
|
| Pillay (2002) |
HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. |
ARHR |
|
| Pillay (2008) |
HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy. |
ARHR |
|
| Pillay (2008) |
Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng province, South Africa in 2002 and 2004. |
Antivir Ther |
|
| Pires (2004) |
Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. |
J Clin Microbiol |
|
| Piyasirisilp (2000) |
A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. |
J Virol |
|
| Piyasujabul (2002) |
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants. |
J Clin Virol. |
|
| Plantier (2009) |
A new human immunodeficiency virus derived from gorillas. |
Nat Med |
|
| Podzamczer (2002) |
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study). |
Antivir Ther |
|
| Podzamczer (2005) |
Early virological failure with a combination of tenofovir, didanosine and efavirenz. |
Antivir Ther |
|
| Pollakis (2003) |
Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. |
ARHR |
|
| Poveda (2008) |
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues. |
AIDS |
|
| Poveda (2008) |
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. |
AIDS |
|
| Powell (2007) |
Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. |
ARHR |
|
| Powell (2007) |
Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. |
ARHR |
|
| Prado (2002) |
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. |
AIDS |
|
| Punzi (2005) |
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic. |
J Med Virol |
|
| Qari (2002) |
Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1. |
J Clin Microbiol |
|
| Qiu (2005) |
Characterization of five nearly full-length genomes of early HIV type 1 strains in Ruili city: implications for the genesis of CRF07_BC and CRF08_BC circulating in China. |
ARHR |
|
| Quinones-Mateu (1995) |
Molecular characterization of human immunodeficiency virus type 1 from Venezuela. |
ARHR |
|
| Quinones-Mateu (1998) |
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in Individuals infected with Group O strains of human immunodeficiency virus type 1. |
J Virol |
|
| Ragonnet-Cronin (2010) |
Longitudinal phylogenetic surveillance identifies distinct patterns of cluster dynamics. |
JAIDS |
|
| Ragonnet-Cronin (2012) |
Adaptive evolution of HIV at HLA epitopes is associated with ethnicity in Canada |
PLoS ONE |
|
| Ragonnet-Cronin (2012) |
Genetic Diversity as a Marker for Timing Infection in HIV-Infected Patients: Evaluation of a 6-Month Window and Comparison With BED. |
J Infect Dis |
|
| Rajesh (2009) |
Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients. |
ARHR |
|
| Ramos (1999) |
Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. |
Emerg Infect Dis |
|
| Ramos (2003) |
New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand. |
ARHR |
|
| Rangel (2010) |
Absence of primary integrase resistance mutations in HIV type 1-infected patients in Venezuela. |
ARHR |
|
| Ravuri (2006) |
Primary drug resistance studies by genotypic analysis in HIV-1 Indian subtype C-infected individuals. |
Direct Genbank Submission |
|
| Razafindratsimandresy (2006) |
High HIV type 1 subtype diversity and few drug resistance mutations among seropositive people detected during the 2005 second generation HIV surveillance in Madagascar. |
ARHR |
|
| Razafindratsimandresy (2007) |
HIV type 1 diversity in the Seychelles. |
ARHR |
|
| Reed (2005) |
High prevalence of a new SIV in cercopithecus erythrotis from the island of Bioko, Equatorial Guinea : molecular characterization of SIVery from tissue samples. |
Direct Genbank Submission |
|
| Reigadas (2013) |
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes. |
J Antimicrob Chemother |
|
| Reinke (2001) |
Natural selection results in conservation of HIV-1 integrase activity despite sequence variability. |
AIDS |
|
| Ren (2007) |
In vitro cross-resistance studies of five different classes of integrase inhibitors in recombinant HIV-1. |
Antivir Ther |
|
| Resch (2005) |
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir. |
J Virol |
|
| Reuman (2010) |
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector. |
AAC |
|
| Rey (2006) |
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients. |
JAIDS |
|
| Rey (2009) |
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. |
AAC |
|
| Reynolds (2012) |
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. |
ARHR |
|
| Rhee (2004) |
Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. |
AAC |
|
| Rhee (2005) |
HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. |
J Infect Dis |
|
| Rhee (2006) |
Genotypic predictors of human immunodeficiency virus type 1 drug resistance. |
PNAS |
|
| Rhee (2009) |
Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms. |
J Infect Dis |
|
| Rhee (2010) |
HIV-1 protease mutations and protease inhibitor cross resistance. |
AAC |
|
| Richard (2004) |
High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. |
ARHR |
|
| Richman (1991) |
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. |
PNAS |
|
| Riddler (2008) |
Class-sparing regimens for initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Rios (2007) |
Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile. |
J Med Virol |
|
| Rodenburg (2001) |
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. |
ARHR |
|
| Rodes (2000) |
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. |
J Clin Microbiol |
|
| Rodes (2002) |
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O. |
J Clin Microbiol |
|
| Rodes (2005) |
Treatment response and drug resistance in patients infected with HIV type 1 group O viruses. |
ARHR |
|
| Rodes (2006) |
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy. |
J Antimicrob Chemother |
|
| Rodrigues (2005) |
Prevalence of ARV resistance mutations and impact of genotyping test in HIV patients with advance disease in Sao Paulo, Brazil. |
J Clin Virol |
|
| Rodrigues (2006) |
Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. |
Virus Res |
|
| Rodrigues (2010) |
Young pregnant women living with HIV/AIDS in Criciuma, Southern Brazil, are infected almost exclusively with HIV type 1 clade C. |
ARHR |
|
| Rodriguez (2006) |
Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin. |
Virology |
|
| Roge (2003) |
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine. |
Antivir Ther |
|
| Rolland (2011) |
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial |
Nat Med |
|
| Rolland (2012) |
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 |
Nature |
|
| Romano (2000) |
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. |
AIDS |
|
| Romano (2002) |
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice. |
JAIDS |
|
| Romano (2002) |
Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118. |
J Infect Dis |
|
| Roques (2004) |
Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. |
AIDS |
|
| Rosen-Zvi (2008) |
Selecting anti-HIV therapies based on a variety of genomic and clinical factors. |
Bioinformatics |
|
| Ross (2006) |
A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. |
AIDS |
|
| Roudinskii (2004) |
Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations. |
J Virol |
|
| Rousseau (2006) |
Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. |
J Virol Methods |
|
| Rousseau (2000) |
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. |
JAIDS |
|
| Rowley (2008) |
The discovery of raltegravir, an integrase inhibitor for the treatment of HIV infection. |
Prog Med Chem |
|
| Ruchansky (2009) |
Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay. |
ARHR |
|
| Ruiz (1996) |
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC. |
AIDS |
|
| Ruiz (1998) |
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients. |
JAIDS |
|
| Sa-Filho (2007) |
Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil. |
ARHR |
|
| Saad (2005) |
HIV type 1 strains common in Europe, Africa, and Asia co-circulate in Yemen. |
ARHR |
|
| Saad (2006) |
Molecular epidemiology of HIV type 1 in Ukraine: birthplace of an epidemic. |
ARHR |
|
| Saad (2006) |
Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. |
ARHR |
|
| Saah (2003) |
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy. |
J Infect Dis |
|
| Sagoe (2007) |
Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naive patients in Accra, Ghana. |
J Clin Virol |
|
| Sahbandar (2009) |
Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. |
ARHR |
|
| Salemi (2008) |
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. |
ARHR |
|
| Salminen (1996) |
Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. |
ARHR |
|
| Sanabani (2006) |
Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. |
Infect Genet Evol |
|
| Sanabani (2006) |
Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. |
ARHR |
|
| Sanabani (2009) |
Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in Sao Paulo, Brazil. |
Virology J |
|
| Sanabani (2010) |
Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. |
Virology J |
|
| Sanabani (2011) |
Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in Sao Paulo, Brazil. |
PLoS ONE |
|
| Sanchez Onoro (2007) |
Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005. |
Enferm Infecc Microbiol Clin |
|
| Sanchez (2006) |
Molecular epidemiology of human immunodeficiency virus-infected individuals in Medellin, Colombia. |
Am J Trop Med Hyg |
|
| Sanders-Buell (2007) |
A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. |
ARHR |
|
| Sanders-Buell (2010) |
Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan. |
ARHR |
|
| Sandstrom (2005) |
Sequences from untreated patients circa 1984. |
Unpublished |
|
| Santiago (2002) |
SIVcpz in wild chimpanzees. |
Science |
|
| Santiago (2003) |
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. |
J Virol |
|
| Santos (2006) |
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. |
AIDS |
|
| Santos (2011) |
Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naive patients from Southern Brazil |
J Clin Virol |
|
| Saskova (2009) |
Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. |
J Virol |
|
| Sato (2006) |
In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor. |
Antiviral Res |
|
| Sato (2009) |
S/GSK1349572 integrase inhibitor resistance profile. |
EACS2009 |
|
| Schapiro (1996) |
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. |
Ann Intern Med |
|
| Schmit (1996) |
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitors ritonavir (ABT-538). |
AIDS |
|
| Schneider (1990) |
Isolation and characterization of HIV-2-ben obtained from a patient with predominantly neurological defects. |
AIDS |
|
| Selimova (2010) |
HIV-1 pol gene subtypes isolated from drug-naive individuals in Russia. |
unpublished |
|
| Sen (2007) |
High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India. |
ARHR |
|
| Seoighe (2007) |
A model of directional selection applied to the evolution of drug resistance in HIV-1. |
Mol Bio Evol |
|
| Servais (2001) |
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. |
J Clin Microbiol |
|
| Servais (2001) |
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor. |
AAC |
|
| Servais (2004) |
HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda. |
ARHR |
|
| Sevigny (2004) |
Cross-Resistance profile of the novel lysine-containing HIV-1 protease inhibitor PL-100. |
IHDRW 2004 |
|
| Sevigny (2006) |
Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor. |
Antiviral Res |
|
| Sevin (2000) |
Methods for investigating the relationship between drug-susceptibility phenotype and HIV-1 genotype with applications to ACTG 333. |
J Infect Dis |
|
| Seyler (2007) |
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa. |
AIDS |
|
| Shafer (1994) |
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. |
J Infect Dis |
|
| Shafer (1995) |
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1 - infected subjects to zidovudine and didanosine combination therapy. |
J Infect Dis |
|
| Shafer (1997) |
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. |
J Virol |
|
| Shafer (1998) |
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. |
Ann Intern Med |
|
| Shafer (1999) |
Sequence and drug susceptibility of HIV-1 type C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. |
ARHR |
|
| Shafer (2003) |
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. |
N Engl J Med |
|
| Shahid (2011) |
HIV-1 circulating recombinant form in Nepal. |
J Virol |
|
| Shang (2007) |
Genotypic resistance mutation to antiretroviral drugs in treatment-naive HIV/AIDS patients in the northeast of China. |
ARHR |
|
| Shi (2004) |
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C recombinant virus. |
ARHR |
|
| Shimura (2007) |
Broad anti-retroviral activity and resistance profile of a novel human immunodeficiency virus integrase inhibitor, Elvitegravir (JTK-303/GS-9137). |
J Virol |
|
| Shirasaka (1995) |
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. |
PNAS |
|
| Shulman (2000) |
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response. |
JAIDS |
|
| Shulman (2001) |
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. |
JAIDS |
|
| Si-Mohamed (2000) |
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. |
J Infect Dis |
|
| Sichtig (2009) |
Evolution of raltegravir resistance during therapy. |
J Antimicrob Chemother |
|
| Sierra (2004) |
The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. |
Infect Genet Evol |
|
| Sierra (2007) |
Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba. |
JAIDS |
|
| Sigaloff (2011) |
Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa. |
ARHR |
|
| Sigaloff (2012) |
High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya. |
ARHR |
|
| Simon (1998) |
Identification of a new human immunodeficiency type 1 group distinct from group M and group O. |
Nat Med |
|
| Simon (2002) |
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. |
AIDS |
|
| Sinha (2012) |
Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naive Population from Northern India. |
AIDS Res Treatm |
|
| Sirivichayakul (2001) |
Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000. |
ARHR |
|
| Sirivichayakul (2003) |
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. |
AIDS |
|
| Sirivichayakul (2008) |
HIV drug resistance transmission threshold survey in Bangkok, Thailand. |
Antivir Ther |
|
| Skinner (1998) |
Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors. |
JAIDS |
|
| Smith (2009) |
A public health model for the molecular surveillance of HIV transmission in San Diego, California. |
AIDS |
|
| Snoeck (2002) |
Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. |
Virus Res |
|
| Snoeck (2004) |
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. |
JAIDS |
|
| Soares (2003) |
Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. |
JAIDS |
|
| Soares (2010) |
Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naive Cameroonian subjects with advanced disease. |
J Clin Virol |
|
| Soares (1997) |
A full-length and replication-competent proviral clone of SIV(AGM) from tantalus monkeys. |
Virology |
|
| Soares (2003) |
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. |
AIDS |
|
| Soheilli (2009) |
Presence of HIV-1 CRF35_AD in Iran. |
ARHR |
|
| Somi (2008) |
Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. |
Antivir Ther |
|
| Soria (2012) |
Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru. |
ARHR |
|
| Soto-Ramirez (1996) |
HIV-1 pol sequences from India fit distinct subtype pattern. |
JAIDS |
|
| Soundararajan (2007) |
Characterization of HIV-1 isolates from antiretroviral drug-naive children in southern India. |
ARHR |
|
| Souquiere (2000) |
Characterization of four newly derived HIV-1 Group N and two SIVcpz strains from Cameroon. |
J Med Primatol. |
|
| Souquiere (2001) |
Wild Mandrillus sphinx are carriers of two types of lentivirus. |
J Virol |
|
| Souquiere (2006) |
The two distinct SIVs infecting Mandrillus sphinx were subjected to differential selection in env region. |
Direct Genbank Submission |
|
| Souza Cavalcanti (2012) |
In-vivo selection of the mutation F121Y in a patient failing raltegravir containing salvage regimen |
Antiviral Res |
|
| Spire (1989) |
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. |
Gene |
|
| Srinivas (1998) |
Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains. |
AAC |
|
| Ssemwanga (2012) |
Low Drug Resistance Levels among Drug-naive Individuals with Recent HIV-1 Infection in a Rural Clinical Cohort in Southwestern Uganda. |
ARHR |
|
| Ssemwanga (2012) |
Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda. |
Clin Infect Dis |
|
| St Clair (1991) |
Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. |
Science |
|
| Stanojevic (2002) |
HIV-1 subtypes in Yugoslavia. |
ARHR |
|
| Steegen (2009) |
Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya. |
AIDS Res Ther |
|
| Struck (2007) |
A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis. |
Direct Genbank Submission |
|
| Su (2003) |
HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. |
AIDS |
|
| Su (2007) |
In vitro selection and characterization of viruses resistant to R1206, a novel nonnucleoside reverse transcriptase inhibitor. |
IHDRW 2007 |
|
| Su (2011) |
HIV-1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. |
ARHR |
|
| Sung (2001) |
Phylogenetic analysis of reverse transcriptase in antiretroviral drug-naive Korean HIV type 1 patients. |
ARHR |
|
| Sutthent (2002) |
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants. |
J Clin Virol |
|
| Swanson (2003) |
Full-length sequence analysis of HIV-1 isolate CM237: a CRF01_AE/B intersubtype recombinant from Thailand. |
ARHR |
|
| Swanson (2003) |
Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. |
ARHR |
|
| Sylla (2008) |
Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso. |
Antivir Ther |
|
| Takebe (2003) |
High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination. |
AIDS |
|
| Takehisa (2001) |
Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus. |
ARHR |
|
| Takehisa (2007) |
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. |
J Virol |
|
| Takemura (2005) |
A novel simian immunodeficiency virus from black mangabey (Lophocebus aterrimus) in the Democratic Republic of Congo. |
J Gen Virol |
|
| Tambuyzer (2009) |
Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors. |
Antivir Ther |
|
| Tamhane (2005) |
Characterization of a long terminal repeat region from an infectious Indian HIV type 2 isolate. |
ARHR |
|
| Tanuri (1999) |
Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil. |
AAC |
|
| Tatsumi (2006) |
Infectious DNA clones of subtype G and CRF02_AG HIV-1 derived from Ghananian isolates. |
Direct Genbank Submission |
|
| Tebit (2002) |
Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. |
ARHR |
|
| Tebit (2006) |
Diversity of HIV in rural Burkina Faso . |
JAIDS |
|
| Tebit (2009) |
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naive patients in Burkina Faso. |
J Med Virol |
|
| Tee (2005) |
Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. |
AIDS |
|
| Tee (2005) |
The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. |
ARHR |
|
| Tee (2006) |
Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. |
Med Microbiol Immunol |
|
| Tee (2006) |
Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. |
JAIDS |
|
| Tee (2009) |
Estimating the date of origin of an HIV-1 circulating recombinant form. |
Virology |
|
| Telan (2011) |
The early phase of an HIV epidemic in a population exposed previously to HCV in the Philippines. |
J Med Virol |
|
| Telan (2012) |
Characterization of HIV Circulating among Risk Populations in the Early Epidemic Phase in the Philippines |
Direct Submission |
|
| Temereanca (2013) |
Transmitted HIV drug resistance in newly diagnosed, treatment-naive Romanian patients. |
J Med Virol |
|
| Theodore (1988) |
Human immunodeficiency virus type 1, isolate Z2 (originally CDC isolate Z34). |
Direct Genbank Submission |
|
| Thomson (2005) |
Full-length recombinant form CRF18_cpx; isolated in Cuba in 1999. |
Direct Genbank Submission |
|
| Thomson (2000) |
Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. |
AIDS |
|
| Thomson (2001) |
HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. |
AIDS |
|
| Thomson (2002) |
Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. |
J Gen Virol |
|
| Thomson (2004) |
Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. |
ARHR |
|
| Thomson (2005) |
Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. |
AIDS |
|
| Thomson (2007) |
New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses. |
ARHR |
|
| Thomson (2009) |
Molecular epidemiology of HIV-1 in St Petersburg, Russia: predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. |
JAIDS |
|
| Thorat (2011) |
Surveillance of Transmitted HIV Type 1 Drug Resistance Among HIV Type 1-Positive Women Attending an Antenatal Clinic in Kakinada, India. |
ARHR |
|
| Tisdale (1993) |
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. |
PNAS |
|
| Tisdale (1995) |
Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. |
AAC |
|
| Tisdale (1997) |
Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. |
AAC |
|
| Toni (2005) |
Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa. |
ARHR |
|
| Toni (2002) |
Primary HIV-1 drug resistance in Abidjan (Cote d'Ivoire) a genotypic and phenotypic study. |
AIDS |
|
| Toni (2003) |
Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire: ANRS 1257 study. |
ARHR |
|
| Toni (2005) |
Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Cote d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission. |
ARHR |
|
| Toni (2007) |
HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d'Ivoire: a 4-year survey, 2002-2006. |
ARHR |
|
| Torti (2005) |
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy. |
Antivir Ther |
|
| Tovanabutra (2001) |
First CRF01_AE/B recombinant of HIV-1 is found in Thailand. |
AIDS |
|
| Tovanabutra (2003) |
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. |
ARHR |
|
| Tovanabutra (2004) |
The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. |
ARHR |
|
| Tovanabutra (2005) |
Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel. |
ARHR |
|
| Tovanabutra (2007) |
Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. |
ARHR |
|
| Tovanabutra (2010) |
Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya. |
ARHR |
|
| Towler (2010) |
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. |
ARHR |
|
| Tramuto (2013) |
Dynamics and molecular evolution of HIV-1 strains in Sicily among antiretroviral naive patients. |
Infect Genet Evol |
|
| Tran (2012) |
No Increase of Drug-Resistant HIV Type 1 Prevalence Among Drug-Naive Individuals in Northern Vietnam. |
ARHR |
|
| Trinh (2012) |
Short communication: Drug resistance mutations in the HIV type 1 protease and reverse transcriptase genes in antiretroviral-naive Vietnamese children. |
ARHR |
|
| Triques (2000) |
Near full length genome sequencing of divergent African HIV type 1 subtype F viruses leads to identification of a new HIV type 1 designated K. |
ARHR |
|
| Tristem (1991) |
Nucleotide sequence of a Guinea-Bissau-derived human immunodeficiency virus type 2 proviral 2clone (HIV-2CAM2). |
J Gen Virol |
|
| Truong (2006) |
Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. |
AIDS |
|
| Truong (2011) |
Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection. |
PLoS ONE |
|
| Tscherning-Casper (2000) |
Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European network on the study of in utero transmission of HIV-1. |
ARHR |
|
| Tshabalala (2011) |
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. |
PLoS ONE |
|
| Tsuiji (2006) |
V118 mutations in the transcriptase gene of HIV-1 from drug-naive hemophiliac patients in Japan. |
Direct Genbank Submission |
|
| Tsujimoto (1989) |
Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill. |
Nature |
|
| Tu (2009) |
Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. |
Transfusion |
|
| Tural (2002) |
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. |
AIDS |
|
| Tymchuck (2010) |
Baseline HIV resistance in Malawi. |
Direct Genbank Submission |
|
| Underwood (2012) |
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults. |
JAIDS |
|
| Vallari (2010) |
Four new HIV-1 group N isolates from Cameroon: prevalence continues to be low. |
ARHR |
|
| Vallari (2011) |
Confirmation of putative HIV-1 group P in Cameroon. |
J Virol |
|
| Valle-Bahena (2006) |
Frequency of protease and reverse transcriptase drug resistance mutations in naive HIV-infected patients. |
Arch Med Res |
|
| Vallejo (1998) |
Tropism, co-receptor use, and genetic characterization of the V3 loop and the protease gene of HIV-1 group O isolates. |
JAIDS |
|
| Van Baelen (2007) |
Low level of baseline resistance to integrase inhibitors L731,988 and L810,810 in randomly selected subtype B and non-B HIV-1 strains. |
IHDRW 2007 |
|
| Van Baelen (2009) |
A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes. |
J Virol Methods |
|
| van der Ende (2000) |
Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy. |
JAIDS |
|
| van der Hoek (2007) |
Characterization of an HIV-1 group M variant that is distinct from the known subtypes. |
ARHR |
|
| van Hal (2009) |
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure. |
Retrovirology |
|
| van Harmelen (2001) |
Characterization of full-length HIV type 1 subtype C sequences from South Africa. |
ARHR |
|
| Van Laethem (2000) |
Patient HIV strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir. |
AIDS |
|
| Van Wesenbeeck (2011) |
Cross-resistance profile determination of two second-generation HIV-1 integrase inhibitors using a panel of recombinant viruses derived from raltegravir-treated clinical isolates. |
AAC |
|
| van Zyl (2011) |
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the western cape, South Africa. |
J Med Virol |
|
| Vanden Haesevelde (1994) |
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. |
J Virol |
|
| Vanden Haesevelde (1996) |
Sequence analysis of a highly divergent HIV-1 related lentivirus from a wild captured chimpanzee. |
Virology |
|
| Varella (2007) |
Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil. |
J Med Virol |
|
| Varghese (2011) |
Phenotypic evidence for NRTI resistance in HIV-1 isolates with the RT mutation K64H. |
Unpublished |
|
| Vaughan (2003) |
Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. |
ARHR |
|
| Vazquez de Parga (2005) |
Analysis of drug resistance-associated mutations in treatment-naive individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union. |
J Med Virol |
|
| Venturi (1999) |
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors. |
Eur J Clin Microbiol Infect Dis |
|
| Venturi (2000) |
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. |
J Infect Dis |
|
| Venturi (2002) |
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. |
Antivir Ther |
|
| Vercauteren (2008) |
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. |
ARHR |
|
| Vercauteren (2009) |
Transmission of drug-resistant HIV-1 is stabilizing in Europe. |
J Infect Dis |
|
| Vergne (2000) |
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. |
J Clin Microbiol |
|
| Vergne (2002) |
Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. |
JAIDS |
|
| Vergne (2003) |
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy. |
AIDS |
|
| Vergne (2006) |
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. |
J Clin Virol |
|
| Verschoor (2004) |
A novel simian immunodeficiency virus isolated from a Schmidt's guenon (Cercopithecus ascanius schmidti). |
J Gen Virol |
|
| Vessiere (2006) |
HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaounde, Cameroon. |
JAIDS |
|
| Vessiere (2010) |
First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon. |
AIDS |
|
| Viani (2006) |
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study. |
J Infect Dis |
|
| Vicente (2001) |
Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance. |
Virus Genes |
|
| Vicenti (2007) |
Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects. |
Clin Infect Dis |
|
| Vidal (2002) |
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine. |
Antivir Ther |
|
| Vidal (2000) |
Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes. |
ARHR |
|
| Vidal (2003) |
High genetic diversity of HIV-1 strains in Chad, West Central Africa. |
JAIDS |
|
| Vidal (2006) |
HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). |
ARHR |
|
| Vidal (2006) |
Identification and molecular characterization of subsubtype A4 in central Africa. |
ARHR |
|
| Vidal (2007) |
HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. |
ARHR |
|
| Vidal (2008) |
Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. |
ARHR |
|
| Vidal (2009) |
Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U. |
ARHR |
|
| Villena (2007) |
Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region. |
J Virol |
|
| Vingerhoets (2005) |
TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. |
J Virol |
|
| Vingerhoets (2008) |
An update of the list of NNRTI mutations associated with decreased virologic response to etravirine (ETR): multivariate analyses on the pooled DUET-1 and DUET-2 clinical trial data. |
IHDRW 2008 |
|
| Vingerhoets (2010) |
Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies. |
AIDS |
|
| Vinogradova (2010) |
Short communication: Molecular epidemiology of HIV type 1 in the Republic of Dagestan, Russian Federation: virtually uniform circulation of subtype A, former Soviet Union variant, with predominance of the V77I(PR) subvariant. |
ARHR |
|
| Vinoles (2005) |
Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay. |
Am J Trop Med Hyg |
|
| Viputtijul (2002) |
Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. |
ARHR |
|
| Visawapoka (2006) |
Circulating and unique recombinant forms of HIV Type 1 containing subsubtype A2. |
ARHR |
|
| von Wyl (2007) |
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. |
Arch Intern Med |
|
| von Wyl (2010) |
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy. |
Clin Infect Dis |
|
| Wainberg (1999) |
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. |
Antivir Ther |
|
| Wallis (2009) |
Varied HIV drug resistance patterns among patients on failing antiretroviral therapy in the South African national roll-out programme. |
JAIDS |
|
| Wallis (2010) |
Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient. |
Virus Genes |
|
| Walter (2000) |
Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy. |
Antivir Ther |
|
| Wang (2008) |
Identification of subtype B, multiple circulating recombinant forms and unique recombinants of HIV type 1 in an MSM cohort in China. |
ARHR |
|
| Wang (2009) |
Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. |
J Virol |
|
| Warachit (2007) |
Aberrant life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines. |
Microbes Infect |
|
| Watanaveeradej (2003) |
Subtype C/CRF01_AE recombinant HIV-1 found in Thailand. |
AIDS |
|
| Watanaveeradej (2006) |
Molecular epidemiology of HIV type 1 in preparation for a phase III prime-boost vaccine trial in Thailand and a new approach to HIV type 1 genotyping. |
ARHR |
|
| Weber (2003) |
Role of baseline pol genotype in HIV-1 fitness evolution. |
JAIDS |
|
| Weber (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Weber (2005) |
Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation. |
J Clin Microbiol |
|
| Weidle (2000) |
Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinal site for monitoring HIV genetic diversity in the United States. |
J Infect Dis |
|
| Weidle (2001) |
Resistance to antiretroviral therapy among patients in Uganda. |
JAIDS |
|
| Whitcomb (2002) |
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates. |
AIDS |
|
| Wilbe (2002) |
Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. |
ARHR |
|
| Wilbe (2003) |
Characterization of novel recombinant HIV-1 genomes using the branching index. |
Virology |
|
| Willliamson (2003) |
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. |
ARHR |
|
| Winslow (1995) |
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. |
ARHR |
|
| Winters (1997) |
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. |
AAC |
|
| Winters (1998) |
Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment. |
J Virol |
|
| Winters (1998) |
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. |
J Clin Invest |
|
| Winters (2000) |
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. |
J Virol |
|
| Winters (2001) |
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs. |
AAC |
|
| Wittkop (2009) |
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort. |
J Antimicrob Chemother |
|
| Wong-Staal (1985) |
Complete nucleotide sequence of the AIDS virus, HTLV-III. |
Nature |
|
| Worobey (2010) |
Island biogeography reveals the deep history of SIV. |
Science |
|
| Wright (2010) |
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. |
J Virol |
|
| Wright (2011) |
Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. |
J Virol |
|
| Wu (2013) |
New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. |
PLoS ONE |
|
| Wu (2003) |
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. |
J Virol |
|
| Yahi (2001) |
Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. |
J Infect Dis |
|
| Yamaguchi (2002) |
Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters. |
ARHR |
|
| Yamaguchi (2003) |
Near full-length genomes of 15 HIV type 1 group O isolates. |
ARHR |
|
| Yamaguchi (2004) |
HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. |
ARHR |
|
| Yamaguchi (2006) |
HIV-1 group N: evidence of ongoing transmission in Cameroon. |
ARHR |
|
| Yamaguchi (2006) |
Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission. |
ARHR |
|
| Yamaguchi (2008) |
Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates. |
ARHR |
|
| Yamaguchi (2009) |
HIV type 1 group M subtype G in Cameroon: five genome sequences. |
ARHR |
|
| Yamaguchi (2010) |
Near full-length sequence of HIV type 1 subtype J strain 04CMU11421 from Cameroon. |
ARHR |
|
| Yamaguchi (1995) |
Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations. |
Biochim Biophys Acta |
|
| Yang (2000) |
Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O. |
ARHR |
|
| Yang (2004) |
Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya. |
ARHR |
|
| Yang (2010) |
Sequences from Angola, Direct submission. |
Direct Genbank Submission |
|
| Yang (2012) |
Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV-1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China |
ARHR |
|
| Yang (2012) |
HIV-1 Sequences from Kenya, Direct Submission. |
Direct Genbank Submission |
|
| Yang (2012) |
HIV-1 Sequences from Vietnam, Direct Submission. |
Direct Genbank Submission |
|
| Yang (2002) |
On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. |
AIDS |
|
| Yang (2003) |
Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. |
J Virol |
|
| Yaotse (2009) |
Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. |
Infect Genet Evol |
|
| Yates (2006) |
In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385. |
AAC |
|
| Ye (2011) |
The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China. |
ARHR |
|
| Ye (2011) |
Sequence analysis of the gag-pol gene of human immunodeficiency virus type 1 of intersubtype (B/C) recombinant strain in Beijing, China. |
ARHR |
|
| Yebra (2009) |
Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). |
ARHR |
|
| Yebra (2010) |
HIV-1 non-B subtypes: high transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability. |
Antiviral Res |
|
| Yerly (2001) |
Nosocomial outbreak of multiple bloodborne viral infections. |
J Infect Dis |
|
| Yerly (2004) |
HIV-1 co/super-infection in intravenous drug users |
AIDS |
|
| Young (1998) |
Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy. |
J Infect Dis |
|
| Young (1995) |
L-743,726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. |
AAC |
|
| Youngpairoj (2012) |
Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon. |
ARHR |
|
| Yu (2009) |
Genetic diversity and drug resistance of HIV type 1 circu |
